Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19

by Bartolo-Cruz, M., Bednarova, E., Chavez, A., Daniels, J.D, Farina, M., Forouhar, F., Fowler, B., Ho, D.D, Hong, S.J, Huang, Y., Hurst, B.L, Iketani, S., Jurtschenko, C., Karan, C., Khanizeman, N., Lauber, M.A, Lee, S., Li, W., Liu, H., McDonald, T., Mohri, H., Nair, M.S, Quinn, C., Rajbhandari, P., Resnick, S.J, Rovis, T., Shion, H., Stockwell, B.R, Stokes, M.E, Tay, N.E.S, Xia, X., Zask, A.
Published 2022

Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19

by Bartolo-Cruz, M., Bednarova, E., Chavez, A., Daniels, J.D, Farina, M., Forouhar, F., Fowler, B., Ho, D.D, Hong, S.J, Huang, Y., Hurst, B.L, Iketani, S., Jurtschenko, C., Karan, C., Khanizeman, N., Lauber, M.A, Lee, S., Li, W., Liu, H., McDonald, T., Mohri, H., Nair, M.S, Quinn, C., Rajbhandari, P., Resnick, S.J, Rovis, T., Shion, H., Stockwell, B.R, Stokes, M.E, Tay, N.E.S, Xia, X., Zask, A.
Published 2022